PedAM
Pediatric Disease Annotations & Medicines
| Disease | myoclonus |
| Phenotype | C0027819|neuroblastoma |
| Sentences | 6 |
| PubMedID- 25224062 | Objective: to investigate the efficacy of combined modality therapy for neuroblastoma in children associated with opsoclonus-myoclonus syndrome (oms-nb). |
| PubMedID- 20110181 | Objective: to compare the clinical data at diagnosis, treatment and neurological outcome in 34 children with opsoclonus-myoclonus syndrome (oms) associated with a detected neuroblastoma or not. |
| PubMedID- 26445726 | Anti-hu antibodies are extremely rare in children, but they have been observed in neuroblastoma with or without opsoclonus-myoclonus syndrome or in limbic encephalitis without associated malignancy.1 however, anti-hu antibodies are not typically associated with clinical features of rasmussen encephalitis (re). |
| PubMedID- 22247816 | Children with opsoclonus myoclonus resulting from a neuroblastoma often retain neurological sequelae. |
| PubMedID- 23198199 | Clinical responses to rituximab in a case of neuroblastoma with refractory opsoclonus myoclonus ataxia syndrome. |
| PubMedID- 21941489 | Furthermore, in young children, neuroblastoma exceptionally manifests with paraneoplastic opsoclonus-myoclonus-ataxia (poma) due to antineuronal nuclear (anti-hu) antibodies [3] which have also been associated with gastrointestinal disturbances, such as constipation, gut dismotility and paralytic ileus [4]. |
Page: 1